Control Bionics Limited Profit Margin

The latest profit margin for CBL.AX is -122.57% as of June 2026. That compares with -105.02% in the prior-year period — down 16.7% year over year. That is below the sector sector average of 13.2%. Investors often review this figure alongside Control Bionics Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, CBL.AX's profit margin moved from -105.02% to -122.57% — a 16.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Control Bionics Limited's valuation or profitability profile.

Against its sector companies, CBL.AX currently prints -122.57% for profit margin, while the sector average sits near 13.2%. That is roughly 1028.6% below the sector mean. Large gaps often invite a closer look at Control Bionics Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Control Bionics Limited converts resources into returns. At -122.57%, CBL.AX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -105.02% in the prior-year period — down 16.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CBL.AX's profit margin (-122.57%), review year-over-year change from -105.02%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.